FTY720, by synergizing with TNF-related apoptosis inducer ligand (TRAIL), has also been shown to reduce tumor burden and induce tumor-specific apoptosis in xenograft breast cancer models without affecting normal cells (Woo et al., 2015). This evidence concerns the gene TNFSF10 and breast cancer.